Pharmacokinetic-pharmacometabolomic approach in early-phase clinical trials: A way forward for targeted therapy in type 2 diabetes
Pharmacometabolomics in early phase clinical trials demonstrate the metabolic profiles of a subject responding to a drug treatment in a controlled environment, whereas pharmacokinetics measure the drug plasma concentration in human circulation. Application of the personalized peak plasma concentrati...
Saved in:
Main Authors: | Tee, Khim Boon, Ibrahim, Luqman, Mohd Hashim, Najihah, Saiman, Mohd Zuwairi, Zakaria, Zaril Harza, Zaman Huri, Hasniza |
---|---|
Format: | Article |
Published: |
MDPI
2022
|
Subjects: | |
Online Access: | http://eprints.um.edu.my/41969/ |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacokinetics and metabolomic profiling of metformin and Andrographis paniculata: A protocol for a crossover randomised controlled trial
by: Tee, Khim Boon, et al.
Published: (2022) -
The Personalization of Clopidogrel Antiplatelet Therapy: The Role of Integrative Pharmacogenetics and Pharmacometabolomics
by: Amin, Arwa M., et al.
Published: (2017) -
Metabolomics, lipidomics and pharmacometabolomics of human hypertension
by: Au, A., et al.
Published: (2017) -
The way forward
Published: (2009) -
Way forward
by: Abdul Rahim, Asiah, et al.
Published: (2022)